Adar1 Capital Management, LLC has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $530 Billion distributed in 266 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Protagonist Therapeutics, Inc with a value of $55.6B, Cytokinetics Inc with a value of $46.3B, Roivant Sciences Ltd. with a value of $43.9B, Ea Series Trust with a value of $37.9B, and Bridge Bio Pharma, Inc. with a value of $32B.
Examining the 13F form we can see an increase of $88.9B in the current position value, from $441B to 530B.
Adar1 Capital Management, LLC is based out at Austin, TX
Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$530 Billion
Healthcare: $402 Billion
ETFs: $20.3 Billion
Industrials: $990 Million
Utilities: $905 Million
Financial Services: $882 Million
Basic Materials: $615 Million
Technology: $564 Million
Communication Services: $513 Million
Other: $477 Million
Stock Holdings Table Market Cap. of Under $50 Millions
